Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ Comments
The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
Rapid rise of GLP-1 medicines brings obesity and eating disorders together
Obesity and eating disorders have traditionally been treated as separate areas of healthcare – but the rapid rise…
Review explores complex links between obesity and cardiovascular diseases
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Obesity, given its strong association with cardiovascular…
UC Berkeley researchers find new potential treatment for obesity and diabetes
Over the past five years, medications called GLP-1s have revolutionized the treatment of metabolic disorders like obesity, diabetes…
An ‘Exercise Pill’ Just Cleared Its First Human Test
Scientists might be inching closer to a breakthrough that some of us lazy bums would very much appreciate:…
Meet the parents putting their kids on Ozempic
By the time he turned ten, Jenna Ceriani’s son was too heavy to play football. The local league…
Amylyx endocrine drug succeeds in key study for low blood sugar
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
Why keto appears to lower blood pressure for some people but not others
From weight loss and insulin sensitivity to fluid balance and inflammation, the review maps several ways ketogenic diets…
Sprint exercise sends a very different molecular signal through the body
Just minutes of all-out sprint work produced a striking surge in circulating proteins and metabolites, revealing how exercise…
Obesity drugs show early promise against PMOS
Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted…
Semaglutide slows blood protein signature linked to future dementia risk
In older adults with cardiovascular disease and overweight or obesity, semaglutide slowed worsening of a blood-based dementia risk…